In a milestone achievement for Indian healthcare, doctors at one of the research institutes in Gurugram have rewritten the future for children suffering from Sickle Cell Disease (SCD). Through a decade-long journey of innovation, compassion, and clinical excellence, the hospital’s paediatric bone marrow transplant team has achieved world-class success rates, positioning India among the global leaders in advanced paediatric transplant care. The landmark study, recently published in the international journal Haemoglobin, analysed the outcomes of 100 paediatric SCD cases treated between 2015 and 2024.
The findings were extraordinary: an overall survival rate of 87%, with 96% success in matched sibling donor transplants and 78% success in half-matched (haploidentical) family donor transplants. These outcomes rival the best international benchmarks, a remarkable feat for a developing nation…
